BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for March 7, 2025

March 7, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arup Laboratories, Inari Medical, Indero, Innovaderm, Phantom Neuro, Qaelon, Revmedica, Sky Medical, SMS Medical, Stryker, Surmodics, Vaxxas.
Read More

Other news to note for March 7, 2025

March 7, 2025
Additional early-stage research and drug discovery news in brief, from: Invivyd, Silexion Therapeutics, Sotio Biotech, Vaxxas.
Read More

Other news to note for March 6, 2025

March 6, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ALX, Atara, Axsome, Hikma, TC Biopharm.
Read More

Other news to note for March 6, 2025

March 6, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Andromeda Surgical, Bioaffinity Technologies, Capstan, Conavi, Icad, Lipogems, Lunit, Nextbiomedical, Ramsoft.
Read More

Other news to note for March 5, 2025

March 5, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelyrin, Alumis, Attmos, Bristol Myers Squibb, Concentra, Centauri, Evotec, Ideaya, Nippon Shinyaku, Regenxbio.
Read More

Other news to note for March 5, 2025

March 5, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aiforia, Atomic Alchemy, Hip Innovation, Oklo, Orion, Sanuwave.
Read More

Other news to note for March 5, 2025

March 5, 2025
Additional early-stage research and drug discovery news in brief, from: Allegro, Nuvectis, Traws.
Read More

Other news to note for March 4, 2025

March 4, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arbutus, Ipsen, Genevant, Marengo, Mitocarex, Nkgen, Oqory, Scisparc, Vincerx, Vivasor.
Read More

Other news to note for March 4, 2025

March 4, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Boston Scientific, Cleerly, Bunkerhill Health, Deepqure, Discure Technologies, Levee Medical, Lunit, Microlight3D, Optellum, Parse Biosciences, Spinal Stabilization Technologies, Volpara.
Read More

Other news to note for March 4, 2025

March 4, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Biond Biologics, Carsgen, Eisai, Epimab, Hansoh, Holling Bio-Pharma, Infex, Idorsia, Ligand, Medigene, Nxera, Sanofi, Sciclone, Silence, Venus Remedies, Ucarsgen.
Read More
Previous 1 2 … 58 59 60 61 62 63 64 65 66 … 1395 1396 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing